Solifenacin: a new drug for the treatment of overactive bladder and detrusor overactivity

ISSN： 1475-0708

Source： Therapy, Vol.3, Iss.4, 2006-07, pp. : 485-494

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insight into New Potential Targets for the Treatment of Overactive Bladder and Detrusor Overactivity

Urologia Internationalis, Vol. 89, Iss. 1, 2012-06 ,pp. : 1-8

Karger

Access to resources Recommend Favorite

An Overview on Mixed Action Drugs for the Treatment of Overactive Bladder and Detrusor Overactivity

Urologia Internationalis, Vol. 89, Iss. 3, 2012-07 ,pp. : 259-269

Karger

Access to resources Recommend Favorite

A review of detrusor overactivity and the overactive bladder after radical prostate cancer treatment

BJU INTERNATIONAL, Vol. 116, Iss. 6, 2015-12 ,pp. : 853-861

John Wiley & Sons Inc

Access to resources Recommend Favorite

Solifenacin for the treatment of overactive bladder

By Robinson Dudley Cardozo Linda

Therapy, Vol. 8, Iss. 6, 2011-11 ,pp. : 691-701

Future Medicine

Access to resources Recommend Favorite

Overactive Bladder Syndrome, Detrusor Overactivity and the Botulinum Toxin

Reviews on Recent Clinical Trials, Vol. 10, Iss. 2, 2015-01 ,pp. : 128-134

Bentham Science Publishers

Access to resources Recommend Favorite